Rationale and results of correction of cognitive dysfunction in patients with chronic heart failure and a reduced left ventricular ejection fraction using a combination of meldonium and gamma-butyrobetaine
Journal Title: Серце і судини - Year 2018, Vol 0, Issue 4
Abstract
The aim — to evaluate the effect of the innovative combination of meltedonium and γ‑butyrobetaine (GBB) on the state of cognitive function, quality of life and endothelial function in patients with chronic heart failure (CHF) and reduced left ventricular ejection fraction (LV EF). Materials and methods. We examined 24 patients with stable CHF and reduced LV EF (< 40 %) of the II — III functional class according to NYHA not older than 75 years who had cognitive impairments identified using standardized testing. All patients underwent general clinical examination using standard methods of psychological testing (Mini‑Mental State Examination (MMSE), Schulte tests, HADS scale, Minnesota Living with Heart Failure Questionnaire (MLHFQ), self‑assessment by patients of household physical activity using the Duke University questionnaire), ultrasound diagnosis of the vasodilating function of the endothelium of the brachial artery (VDFE BA) using a test with reactive hyperemia. The combination of meldonium with GBB was administered in a dose of 2 capsules three times a day (every 8 hours) for 4 weeks. Results and discussion. After treatment with a combination of meldonium and GBB, we observed a statistically significant improvement in cognitive function indicators on the MMSE scale (p < 0.001), Schulte test (p < 0.001), as well as the quality of life by MLHFQ (p = 0.02). While taking the drug, a significant improvement of the endothelium‑dependent vasodilatory response was observed (p < 0.001). No statistically significant effect of the combination of meldonium and GBB on the level of anxiety (HADS‑A scale) and depression (HADS‑D) was observed. Conclusions. Administration to patients with CHF and decreased LV EF of a fixed combination of meldonium and GBB for 4 weeks in addition to standard basic treatment (angiotensin‑converting enzyme inhibitor, b‑blocker, mineralcorticoid receptor antagonist, diuretic) was associated with a statistically significant improvement in cognitive tests results (total score by MMSE, Schulte test run time), quality of life by MLHFQ and significant improvement in VDFE BA according to the test with reactive hyperemia.
Authors and Affiliations
L. G. Voronkov, A. S. Solonovych, A. V. Liashenko
Keywords
Related Articles
- EP ID EP451277
- DOI 10.30978/HV2018-4-62
- Views 111
- Downloads 0
Growth differentiation factor 15 — biomarker of poor prognosis in heart failure
Heart failure (HF) is a major factor contributing to premature death in patients with established cardiovascular (CV) disease. There is a large body of evidence that biological markers, primarily natriuretic peptides, ga...
Features of ultrasound changes of veins in case of varicose disease of lower extremities of pregnant and puerperant women
The aim — to investigate features of venous system alteration in lower extremities during pregnancy and puerperal period using ultrasound Doppler angiography. Materials and methods. The results were analyzed of ultrasou...
Risk factors for complications during recanalization of chronic coronary artery occlusions in patients with coronary artery disease
The aim — to analyze the risk factors for periprocedural complications during recanalization of chronic coronary artery (CA) occlusions in patients with coronary artery disease. Materials and methods. The study included...
Profilaxis of pulmonary embolism with transfascial thrombosis
The aim — to substantiate indices to surgery prophylaxis of pulmonary embolism related to transfascial thrombosis in the inferior vena cava system. Materials and methods. The results of examination and surgery treatment...
Infarction mask of aortoarteritis
Arteritis Takayasu (AT) belongs to the group of systemic vasculitis with a predominant lesion of vessels of large diameter. This disease is characterized by granulomatous inflammation of the aorta and its main branches....